DOW JONES21,917.16-410.32 -1.84%
S&P 5002,584.59-42.06 -1.60%
NASDAQ7,700.10-74.05 -0.95%

RBC Capital Maintains Outperform on Teladoc Health, Raises Price Target to $110

RBC Capital maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $100 to $110.

Benzinga · 01/21/2020 13:28

RBC Capital maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $100 to $110.